CiRC Biosciences is developing regenerative therapies targeting advanced retinitis pigmentosa and dry age-related macular degeneration to prevent and restore vision loss caused by degenerative retinal diseases. Their approach utilizes cell therapy techniques that have potential applications beyond ophthalmology, addressing a critical need for effective treatments in vision restoration.
Funding
$24.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Degenerative retinal diseases, such as advanced retinitis pigmentosa and dry age-related macular degeneration, lead to the progressive loss of functional cells in the eye, resulting in irreversible vision loss. Current treatments are limited in their ability to restore vision once these cells are damaged or lost.
Solution
CiRC Biosciences is developing regenerative medicines that leverage cellular reprogramming to address degenerative eye and brain diseases. Their investigational platform aims to generate functional cells to replace those lost or damaged due to disease, with the goal of restoring function and reversing disease progression. This approach targets the underlying cause of vision loss by regenerating cells, offering a potential therapeutic avenue where traditional methods have limited success. The technology has potential applications beyond ophthalmology, addressing unmet needs in other areas of regenerative medicine.
Target Audience
The primary target audience includes patients with advanced retinitis pigmentosa and dry age-related macular degeneration, as well as those suffering from other degenerative diseases where cell loss leads to functional decline.
Features
- Cellular reprogramming technology to generate functional cells.
- Focus on restoring function and reversing disease progression in degenerative diseases.
- Investigational platform targeting diseases affecting the eye and brain.
- Potential applications beyond ophthalmology.